Mediterranean and Ketogenic Diets Show Real Promise for Endometriosis Pain Relief
A comprehensive review finds targeted nutrition therapy can reduce inflammation, pain, and hormonal imbalance in women with endometriosis and obesity.
Summary
This 2025 review from Current Obesity Reports examines how medical nutrition therapy (MNT) can help manage endometriosis, particularly in women who also have obesity. The authors analyze evidence for the Mediterranean diet, ketogenic diet, and specific supplements including omega-3s, N-acetylcysteine, resveratrol, and vitamins C and E. Key findings show that while endometriosis risk inversely correlates with BMI, obesity worsens disease severity — creating distinct patient phenotypes requiring personalized dietary strategies. The Mediterranean diet's anti-inflammatory and antioxidant properties appear most supported by clinical evidence, while ketogenic diets show mechanistic promise for women with comorbid insulin resistance. Gut microbiota modulation via probiotics emerges as an additional therapeutic target. The review calls for nutritionists as integral members of multidisciplinary endometriosis care teams.
Detailed Summary
Endometriosis affects an estimated 5–10% of women of reproductive age worldwide and up to 30–50% of women with infertility. Despite its enormous burden — characterized by dysmenorrhea, chronic pelvic pain, dyspareunia, and reduced quality of life — treatment remains largely limited to hormonal suppression and surgery, neither of which reliably prevents recurrence. This comprehensive 2025 review in Current Obesity Reports set out to synthesize the available evidence on medical nutrition therapy (MNT) as a complementary, non-pharmacological strategy targeting the core pathophysiological mechanisms of endometriosis: chronic inflammation, oxidative stress, estrogen excess, and immune dysregulation.
A central and counterintuitive finding the authors address is the paradoxical relationship between BMI and endometriosis. Historically, population-level data suggested an inverse association — women with higher BMI had a lower observed risk of developing endometriosis, possibly due to altered estrogen metabolism in adipose tissue and reduced retrograde menstrual flow. However, more recent clinical evidence shows that once endometriosis is established, obesity significantly worsens disease severity, promotes a more pro-inflammatory peritoneal environment, and amplifies insulin resistance and aromatase activity. This duality demands recognition of distinct patient phenotypes — lean versus obese women with endometriosis — and tailored nutritional approaches for each.
The Mediterranean diet (MedDiet) emerges as the most evidence-supported dietary pattern for endometriosis. Rich in omega-3 fatty acids, polyphenols, fiber, and antioxidants, the MedDiet has been associated with decreased dysmenorrhea and pelvic pain scores, improved quality of life metrics, and favorable modulation of prostaglandin synthesis. Its high fiber content facilitates estrogen clearance via gut microbiota, while extra virgin olive oil contributes anti-inflammatory oleocanthal and oleic acid. Several observational and interventional studies reviewed confirm reductions in inflammatory biomarkers (including interleukin-6 and tumor necrosis factor-alpha) and lower oxidative stress markers in women following MedDiet-aligned eating patterns.
The ketogenic diet (KD) represents an emerging area of interest, particularly for women with concomitant obesity or insulin resistance. By inducing physiological ketosis through very-low carbohydrate, high-fat macronutrient ratios, the KD suppresses NLRP3 inflammasome activation, reduces circulating insulin and IGF-1 levels, and may downregulate aromatase activity — all relevant targets in estrogen-driven endometriosis. Preclinical data show reductions in endometriotic lesion size in animal models, and early clinical observations suggest improvements in pain and menstrual regularity. However, the authors stress that clinical trials in human subjects with endometriosis remain scarce, and the KD should currently be reserved for appropriately selected patients under close nutritionist supervision.
Beyond dietary patterns, the review evaluates targeted supplementation. Omega-3 fatty acids (EPA and DHA) competitively inhibit arachidonic acid metabolism, reducing pro-inflammatory prostaglandin E2 and leukotriene B4 synthesis. N-acetylcysteine (NAC) demonstrated a clinically meaningful reduction in endometrioma diameter and pain intensity in a small RCT (endometrioma size decreased from 28 mm to 18 mm vs. increase to 33 mm in controls). Resveratrol showed anti-proliferative effects on endometriotic cells in vitro. Vitamins C and E in combination reduced peritoneal oxidative stress markers and dysmenorrhea scores. Probiotics showed emerging promise by modulating the 'estrobolome' — gut bacterial genes involved in estrogen conjugation and reabsorption — though clinical evidence in endometriosis-specific populations remains limited.
The review concludes by positioning the clinical nutritionist as an indispensable member of multidisciplinary endometriosis care teams, responsible for individualized dietary assessment, phenotype-specific MNT design, supplement prescription, and long-term adherence monitoring. Major limitations acknowledged include the predominantly observational nature of dietary studies, small sample sizes, lack of standardized outcome measures across trials, and absence of dedicated clinical guidelines for nutritional management of endometriosis.
Key Findings
- Obesity worsens endometriosis severity despite an inverse epidemiological association between BMI and initial disease risk, necessitating phenotype-specific nutritional strategies
- Mediterranean diet adherence associated with significant reductions in pelvic pain scores and inflammatory biomarkers (IL-6, TNF-α) across multiple reviewed observational and interventional studies
- N-acetylcysteine (NAC) reduced endometrioma diameter from ~28 mm to ~18 mm in treated women vs. an increase to ~33 mm in controls in a small RCT
- Ketogenic diet reduced endometriotic lesion size in animal models and showed early clinical signals of pain reduction, but human RCT data remain scarce
- Omega-3 supplementation reduces prostaglandin E2 and leukotriene B4 synthesis by competitively inhibiting arachidonic acid metabolism, directly targeting endometriosis-associated inflammation
- Combined vitamins C and E supplementation reduced peritoneal oxidative stress markers and improved dysmenorrhea severity scores in clinical studies
- Gut microbiota ('estrobolome') dysbiosis identified as a mechanistic link between intestinal health and estrogen recycling in endometriosis, supporting prebiotic and probiotic interventions
Methodology
This is a narrative review article synthesizing published evidence from PubMed and related databases on MNT interventions in endometriosis, including dietary patterns, individual supplements, and gut microbiota modulation. The review encompasses animal studies, observational studies, and randomized controlled trials of varying sizes and durations, without a formal systematic review protocol or meta-analytic synthesis. No specific pooled effect sizes or formal quality assessments (e.g., GRADE) are reported, reflecting the heterogeneity of the underlying literature.
Study Limitations
The review is narrative rather than systematic, and most underlying studies are small, observational, or preclinical, limiting the strength of causal conclusions. Clinical trials specifically targeting women with both obesity and endometriosis are largely absent, meaning much of the evidence must be extrapolated from single-condition populations. The authors note the absence of dedicated clinical guidelines for nutritional management of endometriosis and acknowledge that some authors have potential institutional affiliations that could influence perspective, though no explicit financial conflicts of interest were declared.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: